Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
Authors
Keywords
High-density lipoprotein cholesterol, Jinchang cohort, Nonalcoholic fatty liver, Predictive value, Total cholesterol
Journal
Lipids in Health and Disease
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-12
DOI
10.1186/s12944-019-0984-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease
- (2017) Sun Hwa Lee et al. JOURNAL OF CLINICAL ULTRASOUND
- Multiple metals exposure, elevated blood glucose and dysglycemia among Chinese occupational workers
- (2017) Aimin Yang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The independent predictors of non-alcoholic steatohepatitis and its individual histological features.
- (2016) Stefano Ballestri et al. HEPATOLOGY RESEARCH
- Cohort Profile: The China Metal-Exposed Workers Cohort Study (Jinchang Cohort)
- (2016) Yana Bai et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population
- (2016) Moon Hee Yang et al. Journal of Clinical Lipidology
- How to diagnose NAFLD in 2016
- (2016) E. Bugianesi et al. JOURNAL OF HEPATOLOGY
- Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
- (2015) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children
- (2015) Mehmet Agirbasli et al. Journal of Clinical Lipidology
- Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
- (2014) Christopher D. Byrne et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Non-alcoholic fatty liver disease
- (2014) N. Sattar et al. BMJ-British Medical Journal
- Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD)
- (2014) Naim Alkhouri et al. SpringerPlus
- Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
- (2013) Mariana Lazo et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- Association of apolipoprotein B and incidence of metabolic syndrome in Korean men: A 5-years' follow-up study
- (2012) Jae-Hong Ryoo et al. ATHEROSCLEROSIS
- Apolipoprotein B/AI ratio is independently associated with non-alcoholic fatty liver disease in nondiabetic subjects
- (2012) Young Gil Choe et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study
- (2010) Elizabeth K. Speliotes et al. HEPATOLOGY
- Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein
- (2010) P. J. W. H. Kappelle et al. JOURNAL OF INTERNAL MEDICINE
- Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population
- (2009) Amalia Gastaldelli et al. HEPATOLOGY
- Beyond Low-Density Lipoprotein Cholesterol
- (2009) Benoit J. Arsenault et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
- (2008) David Preiss et al. CLINICAL SCIENCE
- Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non–HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein
- (2008) Michael H. Davidson et al. Journal of Clinical Lipidology
- The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment
- (2007) M. Andrikoula et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started